Astellas, Tecnofarma International Ltd. sales and marketing update

Astellas granted Tecnofarma exclusive rights to distribute prostate cancer drug Xtandi enzalutamide in Latin America, excluding Brazil. Regulatory applications have not yet been submitted in Latin America. Astellas said financial terms are not disclosed. ...